Australia markets closed

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1300-0.0100 (-0.88%)
At close: 04:00PM EDT
1.1201 -0.01 (-0.88%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-5,907
-5,907
-1,314
-13,576
-5,458
Depreciation & amortisation
633.008
633.008
769.596
1,025
1,075
Stock-based compensation
444.459
444.459
1,123
0
804.714
Change in working capital
1,540
1,540
-6,705
-232.079
76.693
Other working capital
-10,754
-10,754
-15,657
-5,724
-3,637
Other non-cash items
717.413
717.413
6,769
3,439
291.033
Net cash provided by operating activities
-10,545
-10,545
-15,292
-5,581
-3,432
Cash flows from investing activities
Investments in property, plant and equipment
-208.789
-208.789
-365.197
-143.224
-204.993
Net cash used for investing activities
-208.789
-208.789
-310.197
-143.224
-204.993
Cash flows from financing activities
Debt repayment
0
0
-2,632
-122.469
-415.273
Common stock issued
4,187
4,187
3,370
285.108
3,899
Other financing activities
-793.746
-793.746
-908.602
-21.16
-53.273
Net cash used provided by (used for) financing activities
8,520
8,520
18,653
6,525
3,430
Net change in cash
-2,345
-2,345
3,241
800.892
-206.589
Cash at beginning of period
4,808
4,808
1,567
748.015
956.495
Cash at end of period
2,463
2,463
4,808
1,567
748.015
Free cash flow
Operating cash flow
-10,545
-10,545
-15,292
-5,581
-3,432
Capital expenditure
-208.789
-208.789
-365.197
-143.224
-204.993
Free cash flow
-10,754
-10,754
-15,657
-5,724
-3,637